NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)
$0.3472 0.0152 (4.5783%)
Analysed NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) News Sources
NeuroSense Announces Pricing of Insider-Led PIPE Financing
28-04-2026
yahoo.com
EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots
22-06-2026
yahoo.com
NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease
25-06-2026
yahoo.com
NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
29-06-2026
yahoo.com
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
06-07-2026
yahoo.com
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
22-07-2026
yahoo.com
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
06-08-2026
yahoo.com
NeuroSense Issues CEO Letter to Shareholders
13-08-2026
yahoo.com
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
31-08-2026
yahoo.com
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
10-09-2026
yahoo.com
What is the current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is $0.3472.
NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is $0.0152.
NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is 4.5783%.
What is the most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?
The most recent sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is .
SEC-8K** Filing Available For NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.